Prolongation of canine renal allograft survival by combining tacrolimus with antimetabolic agents.
Zhu
Y
Y
Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pennsylvania 15213, USA.
Suzuki
T
T
Subbotin
V M
VM
Ishizaki
N
N
Jin
M B
MB
Urakami
A
A
Shimamura
T
T
Starzl
T E
TE
Todo
S
S
D000818:Animals; D000963:Antimetabolites / Q000627:therapeutic use* / Q000633:toxicity; D001379:Azathioprine / Q000627:therapeutic use; D004285:Dogs; D004359:Drug Therapy, Combination; D006085:Graft Survival / Q000187:drug effects*; D007166:Immunosuppressive Agents / Q000627:therapeutic use* / Q000633:toxicity; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D012263:Ribonucleosides / Q000627:therapeutic use; D016559:Tacrolimus / Q000627:therapeutic use* / Q000633:toxicity; D014184:Transplantation, Homologous
D000963:Antimetabolites; D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D009173:Mycophenolic Acid; D001379:Azathioprine; D016559:Tacrolimus